Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

HepaRegeniX

Small molecule MKK4 inhibitors to treat acute and chronic liver diseases

Overview Structured Data Issues Contributors Activity

heparegenix.com

Is a

Company

Organization

Company attributes

Industry

Biotechnology

Health technology

Biomedical engineering

Engineering

Location

Germany

CEO

Pitchbook URL

pitchbook.com/profiles...168351-40

Number of Employees (Ranges)

1 – 10

Email Address

info@heparegenix.com

Phone Number

+4970717912810

Investors

Boehringer Ingelheim Venture Fund

High-Tech Gründerfonds

‌

Novo A/S

Founded Date

2017

Total Funding Amount (USD)

37,600,000

Latest Funding Round Date

July 10, 2024

Latest Funding Type

Series C

Patents Assigned (Count)

Country

Germany

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

16,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like HepaRegeniX

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API